A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/130
A61K 39/255 (2006.01) C12N 7/00 (2006.01)
Patent
CA 1251397
ABSTRACT The invention relates to a highly immunogenic virus preparation derivedby attenuation employing serial passages in avian cell cultures and six plaque purification steps from a Marek's disease virus strain, belonging to Avian Herpesvirus serotype-1. The original virus strain MDV CVI-988 was recovered from a healthy chicken (Avian Diseases 16: 108-125, 1972). The live purified Marek's disease vaccine so obtained is innocuous for specific pathogen free Rhode Island Red chickens which are highly susceptible for development of Marek's disease tumours. The monovalent virus preparation, according to the invention, demonstrated in comparison with Marek's disease vaccines based on the same strain, currently in use at a lower cell passage level, an improved protective efficacy against challenge infection by two representatives of virulent Marek's disease virus. The monovalent virus preparation, according to the invention, provided significantly better protection than current MDV CV1-988 vaccine to challenge infection with a representative of the group of newly emerging very virulent strains of Marek's disease virus, MDV RB/lB. The monovalent virus preparation, according to the invention, provided significantly better protection than is HVT FC126 vaccine to challenge infection with another representative of the group of very virulent MD viruses, MDV Tun.
478672
Centraal Diergeneeskundig Instituut
Mccarthy Tetrault Llp
LandOfFree
Live purified marek's disease vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Live purified marek's disease vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Live purified marek's disease vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1318009